Olink Publishes 2023 Annual Report
Olink Publishes 2023 Annual Report
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company's website at https://investors.olink.com/.
瑞典烏普薩拉，2024年3月25日（GLOBE NEWSWIRE）——Olink Holding AB（publ）（“Olink”）（納斯達克股票代碼：OLK）今天宣佈，2023年年度報告現已在公司網站上發佈，網址爲 https://investors.olink.com/。
About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.
關於 Olink
Olink Holding AB（納斯達克股票代碼：OLK）是一家致力於與科學界一起加速跨多個疾病領域的蛋白質組學的公司，以實現新發現並改善患者的生活。Olink提供了一個產品和服務平台，這些產品和服務部署在主要的生物製藥公司以及領先的臨床和學術機構，以加深對實時人類生物學的理解，並通過切實可行和有影響力的科學推動21世紀的醫療保健。該公司成立於2016年，在歐洲、北美和亞洲都享有盛譽。Olink 總部位於瑞典烏普薩拉。
IR contact
David Deuchler, CFA
Gilmartin Group
olink@gilmartinir.com
紅外聯繫人
David Deuchler，特許金融分析師
吉爾馬丁集團
olink@gilmartinir.com
Media contact
Michael B. Gonzales
VP Global Marketing
Mobile: +1 415 308 6467
michael.gonzales@olink.com
媒體聯繫人
邁克爾·岡薩雷斯
全球營銷副總裁
手機：+1 415 308 6467
michael.gonzales@olink.com